A detailed history of Abundance Wealth Counselors transactions in Novartis Ag stock. As of the latest transaction made, Abundance Wealth Counselors holds 12,199 shares of NVS stock, worth $1.3 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
12,199
Previous 11,933 2.23%
Holding current value
$1.3 Million
Previous $1.21 Million 2.07%
% of portfolio
0.27%
Previous 0.31%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$95.27 - $108.47 $25,341 - $28,853
266 Added 2.23%
12,199 $1.18 Million
Q4 2023

Jan 17, 2024

BUY
$92.27 - $101.54 $61,267 - $67,422
664 Added 5.89%
11,933 $1.21 Million
Q3 2023

Oct 30, 2023

BUY
$94.73 - $105.13 $17,525 - $19,449
185 Added 1.67%
11,269 $1.15 Million
Q2 2023

Jul 19, 2023

BUY
$92.52 - $104.91 $1,480 - $1,678
16 Added 0.14%
11,084 $1.12 Million
Q1 2023

May 02, 2023

BUY
$80.03 - $92.81 $19,047 - $22,088
238 Added 2.2%
11,068 $1.02 Million
Q4 2022

Feb 02, 2023

BUY
$75.55 - $92.52 $58,777 - $71,980
778 Added 7.74%
10,830 $982,000
Q3 2022

Oct 31, 2022

BUY
$74.61 - $87.26 $52,003 - $60,820
697 Added 7.45%
10,052 $764,000
Q2 2022

Aug 05, 2022

BUY
$80.52 - $93.75 $80,197 - $93,375
996 Added 11.92%
9,355 $791,000
Q1 2022

Apr 28, 2022

BUY
$80.11 - $90.62 $129,137 - $146,079
1,612 Added 23.89%
8,359 $734,000
Q4 2021

Jan 18, 2022

SELL
$79.7 - $88.13 $33,394 - $36,926
-419 Reduced 5.85%
6,747 $590,000
Q3 2021

Nov 04, 2021

BUY
$81.78 - $95.14 $44,079 - $51,280
539 Added 8.13%
7,166 $586,000
Q2 2021

Jul 26, 2021

SELL
$85.24 - $94.15 $51 Million - $56.3 Million
-598,020 Reduced 98.9%
6,627 $605,000
Q2 2021

Jul 21, 2021

BUY
$85.24 - $94.15 $51.3 Million - $56.7 Million
601,829 Added 21356.6%
604,647 $7,000
Q1 2021

May 06, 2021

BUY
$83.5 - $98.47 $196,475 - $231,699
2,353 Added 506.02%
2,818 $241,000
Q1 2021

May 05, 2021

BUY
$83.5 - $98.47 $38,827 - $45,788
465 New
465 $12,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Abundance Wealth Counselors Portfolio

Follow Abundance Wealth Counselors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abundance Wealth Counselors, based on Form 13F filings with the SEC.

News

Stay updated on Abundance Wealth Counselors with notifications on news.